Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente

Detalhes bibliográficos
Autor(a) principal: Castel-Branco, M. M.
Data de Publicação: 2012
Outros Autores: Caramona, M. M., Fernandez-Llimos, F., Figueiredo, I. V.
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11
Resumo: While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. 
id RCAP_8ad979059e6fa4704899b9080f6f6e20
oai_identifier_str oai:ojs.actafarmaceuticaportuguesa.com:article/11
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Necessidades reais de implementação de novos serviços farmacêuticos centrados no doenteNecessidades reais de implementação de novos serviços farmacêuticos centrados no doentepharmaceutical carepharmaceutical servicespharmacotherapynegative clinical outcomespatient.cuidados farmacêuticosserviços farmacêuticosfarmacoterapiaresultados clínicos negativosdoente.While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. Novos fármacos mais potentes e complexos, menor disponibilidade de médicos e menor acessibilidade ao serviço de saúde, morbilidade e mortalidade relacionadas com medicamentos sempre a aumentar e custos significativos relacionados com o uso incorrecto dos medicamentos justificam plenamente um profissional focado apenas na gestão de toda a medicação do doente. O medicamento é um bem precioso, mas os doentes necessitam de aprender a utilizá-lo. Porventura será essa uma das mais-valias que o farmacêutico, enquanto especialista do medicamento, poderá aportar actualmente ao sistema de saúde: a promoção do uso racional do medicamento, tal como inscrito na legislação em vigor. Uma correcta utilização do medicamento diminuirá significativamente os resultados negativos da farmacoterapia, que se podem manifestar quer como problema de saúde não tratado quer como inefectividade ou insegurança. Os cuidados farmacêuticos correspondem a uma filosofia de actuação assistencial centrada no doente em que o farmacêutico, integrado na equipa de saúde, assume as suas responsabilidades perante a medicação. Concretiza-se em serviços farmacêuticos que, numa atitude preventiva, identificam e actuam sobre factores de risco existentes durante o processo de uso dos medicamentos – dispensa farmacêutica, indicadores de morbilidade prevenível, revisão da medicação – e em serviços que, numa atitude reactiva, identificam resultados negativos e actuam sobre as suas causas – acompanhamento farmacoterapêutico, gestão da doença. O farmacêutico clínico terá de desenvolver novas competências: comunicação, busca de informação, sentido crítico, comportamento ético, trabalho em equipa, liderança. E terá, mais do que nunca, de ser tecnicamente competente: sólida formação em biologia celular, bioquímica, anatomofisiologia, fisiopatologia, farmacologia e farmacoterapia. Terá ainda de aprender a sistematizar e a registar a sua actuação consoante o tipo de serviço prestado. A principal barreira a vencer será a da sua própria mentalidade. Estes não serão apenas novos caminhos de realização profissional: serão respostas concretas a situações reais dos doentes, que desta forma serão melhor cuidados. Acta Farmacêutica Portuguesa2012-12-30T00:00:00Zjournal articleinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11oai:ojs.actafarmaceuticaportuguesa.com:article/11Acta Farmacêutica Portuguesa; v. 2 n. 1 (2013); 15-202182-3340reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporhttps://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11/69Castel-Branco, M. M.Caramona, M. M.Fernandez-Llimos, F.Figueiredo, I. V.info:eu-repo/semantics/openAccess2022-09-05T12:29:44Zoai:ojs.actafarmaceuticaportuguesa.com:article/11Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T14:59:51.848717Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
title Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
spellingShingle Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
Castel-Branco, M. M.
pharmaceutical care
pharmaceutical services
pharmacotherapy
negative clinical outcomes
patient.
cuidados farmacêuticos
serviços farmacêuticos
farmacoterapia
resultados clínicos negativos
doente.
title_short Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
title_full Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
title_fullStr Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
title_full_unstemmed Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
title_sort Necessidades reais de implementação de novos serviços farmacêuticos centrados no doente
author Castel-Branco, M. M.
author_facet Castel-Branco, M. M.
Caramona, M. M.
Fernandez-Llimos, F.
Figueiredo, I. V.
author_role author
author2 Caramona, M. M.
Fernandez-Llimos, F.
Figueiredo, I. V.
author2_role author
author
author
dc.contributor.author.fl_str_mv Castel-Branco, M. M.
Caramona, M. M.
Fernandez-Llimos, F.
Figueiredo, I. V.
dc.subject.por.fl_str_mv pharmaceutical care
pharmaceutical services
pharmacotherapy
negative clinical outcomes
patient.
cuidados farmacêuticos
serviços farmacêuticos
farmacoterapia
resultados clínicos negativos
doente.
topic pharmaceutical care
pharmaceutical services
pharmacotherapy
negative clinical outcomes
patient.
cuidados farmacêuticos
serviços farmacêuticos
farmacoterapia
resultados clínicos negativos
doente.
description While new more potent and complex pharmaceutical agents are becoming available, increasing demands on doctors and the health care system, the increase of drug related morbidity and mortality throughout the world and rising costs related with the incorrect use of medicines make it clear that the identification of a practitioner who is available to focus on the management of all of a patient’s medicines would be an important asset to the future of human health. Medicines are precious, but patients need to learn how to use them. It is possible that this will be one of the advantages that the pharmacist, as a medicine specialist, will bring to the health system, i.e. the promotion of the rational use of medicines as laid down in legislation. The correct use of medicines will significantly decrease the negative outcomes of phar- macotherapy, namely untreated health problems, ineffective treatment and unsafe treatment.Pharmaceutical care is a patient-centered philosophy of assistential practice in which the pharmacist, as a health care team member, has responsibilities in patient medication. There are pharmaceutical services that monitor the process of the use of medicines from a preventive standpoint, identifying risk factors and acting within their constraints – dispensing, preventable morbidity indicators, medication review – and there are pharmaceutical services that monitor the outcomes from a reactive standpoint, identifying negative clinical outcomes and acting on their causes – pharmacotherapy follow-up, disease management. The clinical pharmacist will have to develop new competencies in communication, information retrieval, critical analysis, ethical behavior, teamwork and leadership. And, more than ever, the clinical pharmacist will have to be technically competent, which requires solid training in cellular biology, biochemistry, anatomophysiology, physiopathology, pharmacology and pharmacotherapy. The assistential pharmacist will have to learn to systematize and to register its action in each type of service carried out. The main barrier that he will have to overcome will be his own mind. This will not only provide new ways of boosting the professional satisfaction of the clinical pharmacist but will also provide concrete answers to the real situations of patients, who will ultimately receive better care. 
publishDate 2012
dc.date.none.fl_str_mv 2012-12-30T00:00:00Z
dc.type.driver.fl_str_mv journal article
info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11
oai:ojs.actafarmaceuticaportuguesa.com:article/11
url https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11
identifier_str_mv oai:ojs.actafarmaceuticaportuguesa.com:article/11
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11
https://actafarmaceuticaportuguesa.com/index.php/afp/article/view/11/69
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
publisher.none.fl_str_mv Acta Farmacêutica Portuguesa
dc.source.none.fl_str_mv Acta Farmacêutica Portuguesa; v. 2 n. 1 (2013); 15-20
2182-3340
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799129870961213440